Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-005919
Filing Date
2021-01-20
Accepted
2021-01-20 17:28:20
Documents
2
Period of Report
2020-12-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm213611d1_8ka.htm 8-K/A 28402
2 EXHIBIT 16.1 tm213611d1_ex16-1.htm EX-16.1 2975
  Complete submission text file 0001104659-21-005919.txt   32735
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-38634 | Film No.: 21539607
SIC: 2834 Pharmaceutical Preparations